Implementation of a survivorship care plan for cancer patients
Official title: Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
Run by Indiana University · NCT05346796 · Data updated 2026-11-12
This study tests whether an online care plan can help colorectal cancer survivors manage their health better and follow important check-up guidelines.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Indiana University Academic / other |
| Locations | 1 site (Indianapolis, Indiana) |
| Status | Recruiting |
| Started | September 9, 2022 |
| Main results expected | May 31, 2027 |
| Study ends | May 31, 2027 |
| Registry record updated | June 24, 2026 |
| Trial ID | NCT05346796 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have been diagnosed with Stage I, II, or III colorectal cancer and have completed initial curative treatment within the past year.
✕Probably not a fit
Patients with recurrent colorectal cancer, severe cognitive impairment, or those currently in hospice care may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates the effectiveness of an interactive survivorship care plan delivered through an Internet-based personal health record for colorectal cancer survivors. It combines a randomized clinical effectiveness trial with a mixed methods implementation study to assess how well the survivorship care plan meets the long-term care needs of patients. The study aims to improve adherence to surveillance and preventive care guidelines while addressing unmet symptom needs through tailored self-management tools. By engaging patients in their own care, the trial seeks to enhance overall health outcomes for colorectal cancer survivors.
Why it matters
Potential benefit: If successful, this approach could significantly improve the long-term care and quality of life for colorectal cancer survivors.
How similar studies have gone: Other studies have shown promise in using personalized health records to improve patient engagement and care outcomes, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients must be 18 years or older at the time of consent 2. Patients must have regular (at least weekly) access to an internet connection, whether at home or elsewhere (family or friend). 3. Diagnosis of colon or rectal cancer, Stages I, II, or III (AJCC, American Joint Committee on Cancer) and have undergone initial curative-intent therapy for their CRC diagnosis within the past 12 months. 4. English-speaking Exclusion Criteria: 1. Patient will be excluded if they have had recurrence of their colorectal cancer. 2. Patient's with severe cognitive impairment 3. Patient's with schizophrenia or other psychosis 4. Patients currently in hospice care
Where it's running
-
Indiana University School of Medicine
Indianapolis, Indiana, United States Recruiting
Study contacts
- Study coordinator: David A Haggstrom, MD
- Email: dahaggst@iu.edu
- Phone: (317) 274-9000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Goal setting in a school-based sport program for rural middle schoolers
This project tests whether a 6-week goal-setting program embedded in a school sport program can boost physical activity among 6th–7th graders in two rural Indiana middle schools.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Hydroxychloroquine for AIMSS in breast cancer patients on aromatase inhibitors
This study tests whether hydroxychloroquine can reduce joint pain in people with breast cancer who are taking aromatase inhibitors and have AIMSS.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Sensor-enabled ankle brace for gait and balance testing in adults
Researchers are testing a modified ankle brace with built-in sensors to see if it accurately measures gait and balance compared with standard equipment in healthy adults.
-
Radiation-related heart damage in locally advanced NSCLC tested with PET-CT
This study tests whether PET-CT imaging with 18F-Flurpiridaz can detect early radiation-related heart damage in adults with locally advanced non-small cell lung cancer receiving standard chemoradiation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.